BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 15885826)

  • 21. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique.
    Malaker K; Shukla V; D'Souza H; Weatherburn H
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):257-66. PubMed ID: 15629619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
    Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
    Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing radiation dose to pelvic small bowel in cervical cancer patients treated with Ir-192 intracavitary brachytherapy by using urinary bladder distension.
    Sukhaboon J; Shotelersuk K; Lertsanguansinchai P; Khorprasert C
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S200-6. PubMed ID: 16623029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method.
    Hayashi K; Isohashi F; Akino Y; Wakai N; Mabuchi S; Suzuki O; Seo Y; Ootani Y; Sumida I; Yoshioka Y; Kimura T; Ogawa K
    J Radiat Res; 2015 May; 56(3):546-52. PubMed ID: 25678538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
    Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
    Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
    Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dosimetric parameters derived from whole organ and wall contours for bladder and rectum in cervical cancer patients treated with intracavitary and interstitial brachytherapy.
    Gerber R; Rink A; Croke J; Borg J; Beiki-Ardakani A; Fyles A; Milosevic M; Xie J; Keller H; Han K
    Radiother Oncol; 2018 Jun; 127(3):456-459. PubMed ID: 29426638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.
    Hellebust TP; Dale E; Skjønsberg A; Olsen DR
    Radiother Oncol; 2001 Sep; 60(3):273-80. PubMed ID: 11514007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bladder distension on dosimetry of organs at risk in computer tomography based planning of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Patra NB; Manir KS; Basu S; Goswami J; Kabasi AK; Sarkar SK
    J Contemp Brachytherapy; 2013 Mar; 5(1):3-9. PubMed ID: 23634149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
    Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
    Srivastava AK; Rastogi M; Mishra SP
    J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
    Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of CT-based volumetric dosimetry with traditional prescription points in the treatment of cervical cancer with PDR brachytherapy.
    Lowrey N; Nilsson S; Moutrie Z; Chan P; Cheuk R
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):640-5. PubMed ID: 26223554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan.
    Toita T; Kodaira T; Shinoda A; Uno T; Akino Y; Mitsumori M; Teshima T
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):788-94. PubMed ID: 18191331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparisons between the KKU-model and conventional rectal tubes as markers for checking rectal doses during intracavitary brachytherapy of cervical cancer.
    Padoongcharoen P; Krusun S; Palusuk V; Pesee M; Supaadirek C; Thamronganantasakul K
    Asian Pac J Cancer Prev; 2014; 15(15):6115-20. PubMed ID: 25124583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.